Neurobiology of food intake in health and disease

Nature Reviews Neuroscience

Volumn 15, Issue 6, 2014, Pages 367-378

  Morton, Gregory J ^a   Meek, Thomas H ^a   Schwartz, Michael W ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANOREXIA; BODY WEIGHT; BODY WEIGHT DISORDER; CONNECTOME; DIABETIC HYPERPHAGIA; FEEDING; FOOD INTAKE; HEALTH; HOMEOSTASIS; HUMAN; HYPERPHAGIA; HYPOGLYCEMIA; NEUROBIOLOGY; OBESITY; PATHOGENESIS; PATHOPHYSIOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SATIETY; STRESS;

ANIMALS; BRAIN; EATING; EATING DISORDERS; ENERGY METABOLISM; FEEDING BEHAVIOR; HOMEOSTASIS; HUMANS; NEUROBIOLOGY;

EID: 84901006228     PISSN: 1471003X     EISSN: 14710048     Source Type: Journal    
DOI: 10.1038/nrn3745     Document Type: Review

References (170)

1. Edholm, O. G. Energy balance in man studies carried out by the Division of Human Physiology, National Institute for Medical Research. J. Hum. Nutr. 31, 413-431 (1977
2. Edholm, O. G., Fletcher, J. G., Widdowson, E. M. & McCance, R. A. The energy expenditure and food intake of individual men. Br. J. Nutr. 9, 286-300 (1955
3. Bray, G. A., Flatt, J. P., Volaufova, J., Delany, J. P. & Champagne, C. M. Corrective responses in human food intake identified from an analysis of 7 d food-intake records. Am. J. Clin. Nutr. 88, 1504-1510 (2008
4. Schwartz, M. W. et al. Central nervous system control of food intake. Nature 404, 661-671 (2000
5. Morton, G. J., Cummings, D. E., Baskin, D. G., Barsh, G. S. & Schwartz, M. W. Central nervous system control of food intake and body weight. Nature 443, 289-295 (2006
6. Saper, C. B., Chou, T. C. & Elmquist, J. K. The need to feed: Homeostatic and hedonic control of eating. Neuron 36, 199-211 (2002
7. Nguyen, D. M. & El-Serag, H. B. The epidemiology of obesity. Gastroenterol. Clin. North Am. 39, 1-7 (2010
8. Braun, T. P. & Marks, D. L. Pathophysiology and treatment of inflammatory anorexia in chronic disease. J. Cachexia Sarcopenia Muscle 1, 135-145 (2010
9. Ritter, R. C. & Slusser, P. 5 Thio-D-glucose causes increased feeding and hyperglycemia in the rat. Am. J. Physiol. 238, E141-E144 (1980
10. Kennedy, G. The role of depot fat in the hypothalamic control of food intake in the rat. Proc. R. Soc. Lond. B 140, 578-592 (1953
11. Gao, Q. & Horvath, T. L. Neurobiology of feeding and energy expenditure. Annu. Rev. Neurosci. 30, 367-398 (2007
12. Rosenbaum, M. & Leibel, R. L. Adaptive thermogenesis in humans. Int. J. Obes. (Lond.) 34 (Suppl. 1), 47-55 (2010
13. Zhang, Y. et al. Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425-432 (1994
14. Considine, R. V. et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 334, 292-295 (1996
15. Schwartz, M. W., Peskind, E., Raskind, M., Boyko, E. J. & Porte, D. Jr. Cerebrospinal fluid leptin levels: Relationship to plasma levels and to adiposity in humans. Nature Med. 2, 589-593 (1996
16. Baskin, D. G., Breininger, J. F. & Schwartz, M. W. Leptin receptor mRNA identifies a subpopulation of neuropeptide Y neurons activated by fasting in rat hypothalamus. Diabetes 48, 828-833 (1999
17. Elmquist, J. K., Bjorbaek, C., Ahima, R. S., Flier, J. S. & Saper, C. B. Distributions of leptin receptor mRNA isoforms in the rat brain. J. Comp. Neurol. 395, 535-547 (1998
18. Campfield, L. A., Smith, F. J., Guisez, Y., Devos, R. & Burn, P. Recombinant mouse OB protein: Evidence for a peripheral signal linking adiposity and central neural networks. Science 269, 546-549 (1995
19. Halaas, J. L. et al. Physiological response to long-Term peripheral and central leptin infusion in lean and obese mice. Proc. Natl Acad. Sci. USA 94, 8878-8883 (1997
20. Lee, G. H. et al. Abnormal splicing of the leptin receptor in Diabetic mice. Nature 379, 632-635 (1996
21. Bagdade, J. D., Bierman, E. L. & Porte, D. Jr. The significance of basal insulin levels in the evaluation of the insulin response to glucose in Diabetic and nondiabetic subjects. J. Clin. Invest. 46, 1549-1557 (1967
22. Woods, S. C., Lotter, E. C., McKay, L. D. & Porte, D. Jr. Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons. Nature 282, 503-505 (1979
23. Bruning, J. C. et al. Role of brain insulin receptor in control of body weight and reproduction. Science 289, 2122-2125 (2000
24. Batterham, R. L. et al. Gut hormone PYY3-36 physiologically inhibits food intake. Nature 418, 650-654 (2002
25. Turton, M. D. et al. A role for glucagon-like peptide 1 in the central regulation of feeding. Nature 379, 69-72 (1996
26. Gibbs, J., Young, R. C. & Smith, G. P. Cholecystokinin Decreases food intake in rats. J. Comp. Physiol. Psychol. 84, 488-495 (1973
27. Tschop, M., Smiley, D. L. & Heiman, M. L. Ghrelin induces adiposity in rodents. Nature 407, 908-913 (2000
28. Lam, T. K. Neuronal regulation of homeostasis by nutrient sensing. Nature Med. 16, 392-395 (2010
29. Strubbe, J. H. & Woods, S. C. The timing of meals. Psychol. Rev. 111, 128-141 (2004
30. West, D. B., Fey, D. & Woods, S. C. Cholecystokinin persistently suppresses meal size but not food intake in free-feeding rats. Am. J. Physiol. 246, R776-R787 (1984
31. McMinn, J. E., Sindelar, D. K., Havel, P. J. & Schwartz, M. W. Leptin Deficiency induced by fasting impairs the satiety response to cholecystokinin. Endocrinology 141, 4442-4448 (2000
32. Barrachina, M. D., Martinez, V., Wang, L., Wei, J. Y. & Tache, Y. Synergistic interaction between leptin and cholecystokinin to reduce short-Term food intake in lean mice. Proc. Natl Acad. Sci. USA 94, 10455-10460 (1997
33. Figlewicz, D. P., Stein, L. J., West, D., Porte, D. Jr & Woods, S. C. Intracisternal insulin alters sensitivity to CCK-induced meal suppression in baboons. Am. J. Physiol. 250, R856-R860 (1986
34. Emond, M., Schwartz, G. J., Ladenheim, E. E. & Moran, T. H. Central leptin modulates behavioral and neural responsivity to CCK. Am. J. Physiol. 276, R1545-R1549 (1999
35. Williams, D. L., Baskin, D. G. & Schwartz, M. W. Evidence that intestinal glucagon-like peptide 1 plays a physiological role in satiety. Endocrinology 150, 1680-1687 (2009
36. Hulsey, M. G., Lu, H., Wang, T., Martin, R. J. & Baile, C. A. Intracerebroventricular (i.c.v.) administration of mouse leptin in rats: Behavioral specificity and effects on meal patterns. Physiol. Behav. 65, 445-455 (1998
37. Kahler, A. et al. Chronic administration of OB protein Decreases food intake by selectively reducing meal size in male rats. Am. J. Physiol. 275, R180-R185 (1998
38. McLaughlin, C. L. & Baile, C. A. Decreased sensitivity of Zucker obese rats to the putative satiety agent cholecystokinin. Physiol. Behav. 25, 543-548 (1980
39. Morton, G. J. et al. Leptin regulates insulin sensitivity via phosphatidylinositol 3 OH kinase signaling in mediobasal hypothalamic neurons. Cell. Metab. 2, 411-420 (2005
40. Grill, H. J. et al. Evidence that the caudal brainstem is a target for the inhibitory effect of leptin on food intake. Endocrinology 143, 239-246 (2002
41. Morton, G. J. et al. Leptin action in the forebrain regulates the hindbrain response to satiety signals. J. Clin. Invest. 115, 703-710 (2005
42. Barrera, J. G., Sandoval, D. A., D'Alessio, D. A. & Seeley, R. J. GLP 1 and energy balance: An integrated model of short-Term and long-Term control. Nature Rev. Endocrinol. 7, 507-516 (2011
43. Berthoud, H. R. Homeostatic and non-homeostatic pathways involved in the control of food intake and energy balance. Obesity, 14, (Suppl. 5), 197S-200S (2006
44. Figlewicz, D. P. Adiposity signals and food reward: Expanding the CNS roles of insulin and leptin. Am. J. Physiol. Regul. Integr. Comp. Physiol. 284, R882-R892 (2003
45. Dossat, A. M., Lilly, N., Kay, K. & Williams, D. L. Glucagon-like peptide 1 receptors in nucleus accumbens affect food intake. J. Neurosci. 31, 14453-14457 (2011
46. Mehta, S. et al. Regional brain response to visual food cues is a marker of satiety that predicts food choice. Am. J. Clin. Nutr. 96, 989-999 (2012
47. Nijs, I. M., Muris, P., Euser, A. S. & Franken, I. H. Differences in attention to food and food intake between overweight/obese and normal-weight females under conditions of hunger and satiety. Appetite 54, 243-254 (2010
48. Figlewicz, D. P. & Sipols, A. J. Energy regulatory signals and food reward. Pharmacol. Biochem. Behav. 97, 15-24 (2010
49. Fulton, S., Woodside, B. & Shizgal, P. Modulation of brain reward circuitry by leptin. Science 287, 125-128 (2000
50. Farooqi, I. S. et al. Leptin regulates striatal regions and human eating behavior. Science 317, 1355 (2007
51. Berthoud, H. R., Lenard, N. R. & Shin, A. C. Food reward, hyperphagia, and obesity. Am. J. Physiol. Regul. Integr. Comp. Physiol. 300, R1266-R1277 (2011
52. Stice, E., Figlewicz, D. P., Gosnell, B. A., Levine, A. S. & Pratt, W. E. The contribution of brain reward circuits to the obesity epidemic. Neurosci. Biobehav. Rev. 37, 2047- 2058 (2012
53. Kelley, A. E., Baldo, B. A., Pratt, W. E. & Will, M. J. Corticostriatal-hypothalamic circuitry and food motivation: Integration of energy, action and reward. Physiol. Behav. 86, 773-795 (2005
54. Leinninger, G. M. et al. Leptin acts via leptin receptor-expressing lateral hypothalamic neurons to modulate the mesolimbic dopamine system and suppress feeding. Cell. Metab. 10, 89-98 (2009
55. Hahn, T. M., Breininger, J. F., Baskin, D. G. & Schwartz, M. W. Coexpression of Agrp and NPY in fasting-Activated hypothalamic neurons. Nature Neurosci. 1, 271-272 (1998
56. Hagan, M. M. et al. Long-Term orexigenic effects of AgRP-(83 - 132) involve mechanisms other than melanocortin receptor blockade. Am. J. Physiol. Regul. Integr. Comp. Physiol. 279, R47-R52 (2000
57. Cowley, M. A. et al. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 411, 480-484 (2001
58. Spanswick, D., Smith, M. A., Groppi, V. E., Logan, S. D. & Ashford, M. L. Leptin inhibits hypothalamic neurons by activation of ATP-sensitive potassium channels. Nature 390, 521-525 (1997
59. Spanswick, D., Smith, M. A., Mirshamsi, S., Routh, V. H. & Ashford, M. L. Insulin activates ATP-sensitive K+ channels in hypothalamic neurons of lean, but not obese rats. Nature Neurosci. 3, 757-758 (2000
60. Cowley, M. A. et al. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 37, 649-661 (2003
61. Schwartz, M. W. et al. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 45, 531-535 (1996
62. Schwartz, M. W. et al. Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus. Diabetes 46, 2119-2123 (1997
63. Fan, W., Boston, B. A., Kesterson, R. A., Hruby, V. J. & Cone, R. D. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385, 165-168 (1997
64. Williams, K. W. et al. Segregation of acute leptin and insulin effects in Distinct populations of arcuate proopiomelanocortin neurons. J. Neurosci. 30, 2472-2479 (2010
65. Hill, J. W. et al. Direct insulin and leptin action on pro-opiomelanocortin neurons is required for normal glucose homeostasis and fertility. Cell. Metab. 11, 286-297 (2010
66. Sohn, J. W. et al. Serotonin 2C receptor activates a distinct population of arcuate pro-opiomelanocortin neurons via TRPC channels. Neuron 71, 488-497 (2011
67. Sohn, J. W., Elmquist, J. K. & Williams, K. W. Neuronal circuits that regulate feeding behavior and metabolism. Trends Neurosci. 36, 504-512 (2013
68. Gautron, L. & Elmquist, J. K. Sixteen years and counting: An update on leptin in energy balance. J. Clin. Invest. 121, 2087-2093 (2011
69. van De Wall, E. et al. Collective and individual functions of leptin receptor modulated neurons controlling metabolism and ingestion. Endocrinology 149, 1773-1785 (2008
70. Ring, L. E. & Zeltser, L. M. Disruption of hypothalamic leptin signaling in mice leads to early-onset obesity, but physiological adaptations in mature animals stabilize adiposity levels. J. Clin. Invest. 120, 2931-2941 (2010
71. Dhillon, H. et al. Leptin Directly activates SF1 neurons in the VMH, and this action by leptin is required for normal body-weight homeostasis. Neuron 49, 191-203 (2006
72. Fulton, S. et al. Leptin regulation of the mesoaccumbens dopamine pathway. Neuron 51, 811-822 (2006
73. Hommel, J. D. et al. Leptin receptor signaling in midbrain Dopamine neurons regulates feeding. Neuron 51, 801-810 (2006
74. Hayes, M. R. et al. Endogenous leptin signaling in the caudal nucleus tractus solitarius and area postrema is required for energy balance regulation. Cell. Metab. 11, 77-83 (2010
75. Vong, L. et al. Leptin action on GABAergic neurons prevents obesity and reduces inhibitory tone to POMC neurons. Neuron 71, 142-154 (2011
76. Balthasar, N. et al. Leptin receptor signaling in POMC neurons is required for normal body weight homeostasis. Neuron 42, 983-991 (2004
77. Leshan, R. L., Greenwald-Yarnell, M., Patterson, C. M., Gonzalez, I. E. & Myers, M. G. Jr. Leptin action through hypothalamic nitric oxide synthase 1 expressing neurons controls energy balance. Nature Med. 18, 820-823 (2012
78. Tong, Q., Ye, C. P., Jones, J. E., Elmquist, J. K. & Lowell, B. B. Synaptic release of GABA by AgRP neurons is required for normal regulation of energy balance. Nature Neurosci. 11, 998-1000 (2008
79. Wu, Q., Boyle, M. P. & Palmiter, R. D. Loss of GABAergic signaling by AgRP neurons to the parabrachial nucleus leads to starvation. Cell 137, 1225-1234 (2009
80. Wu, Q., Clark, M. S. & Palmiter, R. D. Deciphering a neuronal circuit that mediates appetite. Nature 483, 594-597 (2012
81. Carter, M. E., Soden, M. E., Zweifel, L. S. & Palmiter, R. D. Genetic identification of a neural circuit that suppresses appetite. Nature 503, 111-114 (2013
82. Kramer, R. H., Mourot, A. & Adesnik, H. Optogenetic pharmacology for control of native neuronal signaling proteins. Nature Neurosci. 16, 816-823 (2013
83. Packer, A. M., Roska, B. & Hausser, M. Targeting neurons and photons for optogenetics. Nature Neurosci. 16, 805-815 (2013
84. Aponte, Y., Atasoy, D. & Sternson, S. M. AGRP neurons are sufficient to orchestrate feeding behavior rapidly and without training. Nature Neurosci. 14, 351-355 (2011
85. Atasoy, D., Betley, J. N., Su, H. H. & Sternson, S. M. Deconstruction of a neural circuit for hunger. Nature 488, 172-177 (2012
86. Krashes, M. J. et al. Rapid, reversible activation of AgRP neurons drives feeding behavior in mice. J. Clin. Invest. 121, 1424-1428 (2011
87. White, J. D. & Kershaw, M. Increased hypothalamic neuropeptide Y expression following food deprivation. Mol. Cell Neurosci. 1, 41-48 (1990
88. Sipols, A. J., Baskin, D. G. & Schwartz, M. W. Effect of intracerebroventricular insulin infusion on Diabetic hyperphagia and hypothalamic neuropeptide gene expression. Diabetes 44, 147-151 (1995
89. Wilding, J. P. et al. Increased neuropeptide-Y messenger ribonucleic acid (mRNA) and decreased neurotensin mRNA in the hypothalamus of the obese (ob/ob) mouse. Endocrinology 132, 1939-1944 (1993
90. Krashes, M. J., Shah, B. P., Koda, S. & Lowell, B. B. Rapid versus delayed stimulation of feeding by the endogenously released AgRP neuron mediators GABA, NPY, and AgRP. Cell. Metab. 18, 588-595 (2013
91. Leibowitz, S. F., Hammer, N. J. & Chang, K. Hypothalamic paraventricular nucleus lesions produce overeating and obesity in the rat. Physiol. Behav. 27, 1031-1040 (1981
92. Huszar, D. et al. Targeted disruption of the melanocortin 4 receptor results in obesity in mice. Cell 88, 131-141 (1997
93. Vaisse, C., Clement, K., Guy Grand, B. & Froguel, P. A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nature Genet. 20, 113-114 (1998
94. Yeo, G. S. et al. A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nature Genet. 20, 111-112 (1998
95. Farooqi, I. S. et al. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N. Engl. J. Med. 348, 1085-1095 (2003
96. Mountjoy, K. G., Mortrud, M. T., Low, M. J., Simerly, R. B. & Cone, R. D. Localization of the melanocortin 4 receptor (MC4 R) in neuroendocrine and autonomic control circuits in the brain. Mol. Endocrinol. 8, 1298-1308 (1994
97. Cowley, M. A. et al. Integration of NPY, AGRP, and melanocortin signals in the hypothalamic paraventricular nucleus: Evidence of a cellular basis for the adipostat. Neuron 24, 155-163 (1999
98. Giraudo, S. Q., Billington, C. J. & Levine, A. S. Feeding effects of hypothalamic injection of melanocortin 4 receptor ligands. Brain Res. 809, 302-306 (1998
99. Balthasar, N. et al. Divergence of melanocortin pathways in the control of food intake and energy expenditure. Cell 123, 493-505 (2005
100. Rossi, J. et al. Melanocortin 4 receptors expressed by cholinergic neurons regulate energy balance and glucose homeostasis. Cell. Metab. 13, 195-204 (2011
101. Arletti, R., Benelli, A. & Bertolini, A. Influence of oxytocin on feeding behavior in the rat. Peptides 10, 89-93 (1989
102. Arletti, R., Benelli, A. & Bertolini, A. Oxytocin inhibits food and fluid intake in rats. Physiol. Behav. 48, 825-830 (1990
103. Olson, B. R. et al. Oxytocin and an oxytocin agonist administered centrally decrease food intake in rats. Peptides 12, 113-118 (1991
104. Morton, G. J. et al. Peripheral oxytocin suppresses food intake and causes weight loss in Diet-induced obese rats. Am. J. Physiol. Endocrinol. Metab. 302, E134-E144 (2012
105. Blevins, J. E. & Ho, J. M. Role of oxytocin signaling in the regulation of body weight. Rev. Endocr. Metab. Disord. 14, 311-329 (2013
106. Blevins, J. E., Eakin, T. J., Murphy, J. A., Schwartz, M. W. & Baskin, D. G. Oxytocin innervation of caudal brainstem nuclei activated by cholecystokinin. Brain Res. 993, 30-41 (2003
107. Blevins, J. E., Schwartz, M. W. & Baskin, D. G. Evidence that paraventricular nucleus oxytocin neurons link hypothalamic leptin action to caudal brainstem nuclei controlling meal size. Am. J. Physiol. Regul. Integr. Comp. Physiol. 287, R87-R96 (2004
108. Kublaoui, B. M., Gemelli, T., Tolson, K. P., Wang, Y. & Zinn, A. R. Oxytocin Deficiency mediates hyperphagic obesity of Sim1 haploinsufficient mice. Mol. Endocrinol. 22, 1723-1734 (2008
109. Bonnefond, A. et al. Loss-of-function mutations in SIM1 contribute to obesity and Prader-Willi-like features. J. Clin. Invest. 123, 3037-3041 (2013
110. Holder, J. L. Jr, Butte, N. F. & Zinn, A. R. Profound obesity associated with a balanced translocation that disrupts the SIM1 gene. Hum. Mol. Genet. 9, 101-108 (2000
111. Ramachandrappa, S. et al. Rare variants in single-minded 1 (SIM1) are associated with severe obesity. J. Clin. Invest. 123, 3042-3050 (2013
112. Swaab, D. F., Purba, J. S. & Hofman, M. A. Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader- Willi syndrome: A study of five cases. J. Clin. Endocrinol. Metab. 80, 573-579 (1995
113. Camerino, C. Low sympathetic tone and obese phenotype in oxytocin-deficient mice. Obesity 17, 980-984 (2009
114. Takayanagi, Y. et al. Oxytocin receptor-deficient mice developed late-onset obesity. Neuroreport 19, 951-955 (2008
115. Beall, C., Ashford, M. L. & McCrimmon, R. J. The physiology and pathophysiology of the neural control of the counterregulatory response. Am. J. Physiol. Regul. Integr. Comp. Physiol. 302, R215-R223 (2012
116. Gerich, J. E. et al. Prevention of human Diabetic ketoacidosis by somatostatin. Evidence for an essential role of glucagon. N. Engl. J. Med. 292, 985-989 (1975
117. Garber, A. J. et al. The role of adrenergic mechanisms in the substrate and hormonal response to insulin-induced hypoglycemia in man. J. Clin. Invest. 58, 7-15 (1976
118. Rizza, R. A., Cryer, P. E. & Gerich, J. E. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined α-And β-Adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia. J. Clin. Invest. 64, 62-71 (1979
119. Ritter, S., Li, A. J., Wang, Q. & Dinh, T. T. Minireview: The value of looking backward: The essential role of the hindbrain in counterregulatory responses to glucose deficit. Endocrinology 152, 4019-4032 (2011
120. McCrimmon, R. J. & Sherwin, R. S. Hypoglycemia in type 1 diabetes. Diabetes 59, 2333-2339 (2010
121. Routh, V. H. Glucose-sensing neurons: Are they physiologically relevant?. Physiol. Behav. 76, 403-413 (2002
122. Watts, A. G. & Donovan, C. M. Sweet talk in the brain: Glucosensing, neural networks, and hypoglycemic counterregulation. Front. Neuroendocrinol. 31, 32-43 (2010
123. Dryden, S., Pickavance, L., Henderson, L. & Williams, G. Hyperphagia induced by hypoglycemia in rats is independent of leptin and hypothalamic neuropeptide Y. (NPY). Peptides 19, 1549-1555 (1998
124. Russell-Jones, D. & Khan, R. Insulin-Associated weight gain in Diabetes - causes, effects and coping strategies. Diabetes Obes. Metab. 9, 799-812 (2007
125. Sindelar, D. K. et al. Neuropeptide Y is required for hyperphagic feeding in response to neuroglucopenia. Endocrinology 145, 3363-3368 (2004
126. Sergeyev, V., Broberger, C., Gorbatyuk, O. & Hokfelt, T. Effect of 2 mercaptoacetate and 2 deoxy-D-glucose administration on the expression of NPY, AGRP, POMC, MCH and hypocretin/orexin in the rat hypothalamus. Neuroreport 11, 117-121 (2000
127. Luquet, S., Phillips, C. T. & Palmiter, R. D. NPY/AgRP neurons are not essential for feeding responses to glucoprivation. Peptides 28, 214-225 (2007
128. Corrin, S. E., McCarthy, H. D., McKibbin, P. E. & Williams, G. Unchanged hypothalamic neuropeptide Y concentrations in hyperphagic, hypoglycemic rats: Evidence for specific metabolic regulation of hypothalamic NPY. Peptides 12, 425-430 (1991
129. Ritter, S., Bugarith, K. & Dinh, T. T. Immunotoxic destruction of distinct catecholamine subgroups produces selective impairment of glucoregulatory responses and neuronal activation. J. Comp. Neurol. 432, 197-216 (2001
130. Havel, P. J. et al. Marked and rapid decreases of circulating leptin in streptozotocin Diabetic rats: Reversal by insulin. Am. J. Physiol. 274, R1482-R1491 (1998
131. American Diabetes Association. Standards of medical care in Diabetes - 2011. Diabetes Care 34 (Suppl. 1), 11-61 (2011
132. Kumaresan, P. & Turner, C. W. Effect of alloxan on feed consumption and on replacement therapy with graded levels of insulin in rats. Proc. Soc. Exp. Biol. Med. 122, 526-527 (1966
133. Ahima, R. S. et al. Role of leptin in the neuroendocrince response to fasting. Nature 382, 250-252 (1996
134. Bray, G. A., Fisler, J. & York, D. A. Neuroendocrine control of the development of obesity: Understanding gained from studies of experimental animal models. Front. Neuroendocrinol. 11, 128-181 (1990
135. Fujikawa, T., Chuang, J. C., Sakata, I., Ramadori, G. & Coppari, R. Leptin therapy improves insulin-deficient type 1 diabetes by CNS-dependent mechanisms in mice. Proc. Natl Acad. Sci. USA 107, 17391-17396 (2010
136. German, J. P. et al. Leptin activates a novel CNS mechanism for insulin-independent normalization of severe diabetic hyperglycemia. Endocrinology 152, 394-404 (2011
137. Hidaka, S. et al. Chronic central leptin infusion restores hyperglycemia independent of food intake and insulin level in streptozotocin-induced diabetic rats. FASEB J. 16, 509-518 (2002
138. Lin, C. Y., Higginbotham, D. A., Judd, R. L. & White, B. D. Central leptin increases insulin sensitivity in streptozotocin-induced diabetic rats. Am. J. Physiol. Endocrinol. Metab. 282, E1084-E1091 (2002
139. Peters, A. et al. The selfish brain: Competition for energy resources. Neurosci. Biobehav. Rev. 28, 143-180 (2004
140. Schwartz, M. W. & Niswender, K. D. Adiposity signaling and biological defense against weight gain: Absence of protection or central hormone resistance?. J. Clin. Endocrinol. Metab. 89, 5889-5897 (2004
141. Ryan, K. K., Woods, S. C. & Seeley, R. J. Central nervous system mechanisms linking the consumption of palatable high-fat diets to the defense of greater adiposity. Cell. Metab. 15, 137-149 (2012
142. Knowler, W. C. et al. 10 year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 374, 1677-1686 (2009
143. Safer, D. J. Diet, behavior modification, and exercise: A review of obesity treatments from a long-Term perspective. South Med. J. 84, 1470-1474 (1991
144. Hagan, M. M. et al. Role of the CNS melanocortin system in the response to overfeeding. J. Neurosci. 19, 2362-2367 (1999
145. Sims, E. A. et al. Experimental obesity in man. Trans. Assoc. Am. Physicians 81, 153-170 (1968
146. Deriaz, O., Fournier, G., Tremblay, A., Despres, J. P. & Bouchard, C. Lean-body-mass composition and resting energy expenditure before and after long-Term overfeeding. Am. J. Clin. Nutr. 56, 840-847 (1992
147. Diaz, E. O., Prentice, A. M., Goldberg, G. R., Murgatroyd, P. R. & Coward, W. A. Metabolic response to experimental overfeeding in lean and overweight healthy volunteers. Am. J. Clin. Nutr. 56, 641-655 (1992
148. Leibel, R. L., Rosenbaum, M. & Hirsch, J. Changes in energy expenditure resulting from altered body weight. N. Engl. J. Med. 332, 621-628 (1995
149. Sims, E. A. et al. Endocrine and metabolic effects of experimental obesity in man. Recent Prog. Horm. Res. 29, 457-496 (1973
150. Farooqi, I. S. et al. Effects of recombinant leptin therapy in a child with congenital leptin Deficiency. N. Engl. J. Med. 341, 879-884 (1999
151. El-Haschimi, K., Pierroz, D. D., Hileman, S. M., Bjorbaek, C. & Flier, J. S. Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. J. Clin. Invest. 105, 1827-1832 (2000
152. Heymsfield, S. B. et al. Recombinant leptin for weight loss in obese and lean adults: A randomized, controlled, dose-escalation trial. JAMA 282, 1568-1575 (1999
153. Myers, M. G. Jr., Leibel, R. L., Seeley, R. J. & Schwartz, M. W. Obesity and leptin resistance: Distinguishing cause from effect. Trends Endocrinol. Metab. 21, 643-651 (2010
154. Xu, H. et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112, 1821-1830 (2003
155. Weisberg, S. P. et al. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112, 1796-1808 (2003
156. Hotamisligil, G. S. Inflammation and metabolic disorders. Nature 444, 860-867 (2006
157. Posey, K. et al. Hypothalamic proinflammatory lipid accumulation, inflammation, and insulin resistance in rats fed a high-fat diet. Am. J. Physiol. Endocrinol. Metab. 296, E1003-E1012 (2008
158. De Souza, C. T. et al. Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. Endocrinology 146, 4192-4199 (2005
159. Thaler, J. P. et al. Obesity is associated with hypothalamic injury in rodents and humans. J. Clin. Invest. 122, 153-162 (2012
160. Zhang, X. et al. Hypothalamic IKKβ/NF-κB and ER stress link overnutrition to energy imbalance and obesity. Cell 135, 61-73 (2008
161. Thaler, J. P., Guyenet, S. J., Dorfman, M. D., Wisse, B. E. & Schwartz, M. W. Hypothalamic inflammation: Marker or mechanism of obesity pathogenesis?. Diabetes 62, 2629-2634 (2013
162. Reilly, S. The parabrachial nucleus and conditioned taste aversion. Brain Res. Bull. 48, 239-254 (1999
163. Reilly, S. & Trifunovic, R. Lateral parabrachial nucleus lesions in the rat: Aversive and appetitive gustatory conditioning. Brain Res. Bull. 52, 269-278 (2000
164. Reilly, S. & Trifunovic, R. Lateral parabrachial nucleus lesions in the rat: Neophobia and conditioned taste aversion. Brain Res. Bull. 55, 359-366 (2001
165. Grossberg, A. J., Scarlett, J. M. & Marks, D. L. Hypothalamic mechanisms in cachexia. Physiol. Behav. 100, 478-489 (2010
166. Stefater, M. A., Wilson-Perez, H. E., Chambers, A. P., Sandoval, D. A. & Seeley, R. J. All bariatric surgeries are not created equal: Insights from mechanistic comparisons. Endocr. Rev. 33, 595-622 (2012
167. Berglund, E. D. et al. Serotonin 2C receptors in pro-opiomelanocortin neurons regulate energy and glucose homeostasis. J. Clin. Invest. 123, 5061-5070 (2013
168. Smith, S. R. et al. Multicenter, placebo-controlled trial of lorcaserin for weight management. N. Engl. J. Med. 363, 245-256 (2010
169. Gadde, K. M. et al. Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): A randomised, placebo-controlled, phase 3 trial. Lancet 377, 1341-1352 (2011
170. Marx, J. Cellular warriors at the battle of the bulge. Science 299, 846-849 (2003 Diseases Diseases Diseases Diseases